See "Remarks"
Thu, Mar 5, 2026
Mar 5
14,150 shares @ $31.67
Decreased holdings by -67.60%
Net across this filing: 0.00% (+0 shares)
Largest trade (out of 12)
Planned (10b5-1)
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Net holdings across this filing: +0.0% (+0 shares)
Price 37% above 200-day moving average
TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
Health CarePharmaceuticals
1D0.00%
1W+0.96%
1M+19.47%
3M+6.36%
6M—
1Y—